Evidence map›Paper›PMID 34604859›Full record

ArticleJACS Au2021

Shielding Effect of Nanomicelles: Stable and Catalytically Active Oxidizable Pd(0) Nanoparticle Catalyst Compatible for Cross-Couplings of Water-Sensitive Acid Chlorides in Water.

Tharique N Ansari, Sudripet Sharma, Susanta Hazra, Jacek B Jasinski, Andrew J Wilson, Frederick Hicks, David K Leahy, Sachin Handa

Open access · goldAbstract read
In one paragraph

Article in JACS Au, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. [(NHC)PdClThe Journal of organic chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tharique N AnsariDepartment of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States.
Sudripet SharmaDepartment of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States.
Susanta HazraDepartment of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States.
Jacek B JasinskiMaterials Characterization, Conn Center for Renewable Energy Research University of Louisville, Louisville, Kentucky 40292, United States.ORCID https://orcid.org/0000-0002-1297-6145
Andrew J WilsonDepartment of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States.ORCID https://orcid.org/0000-0003-3427-810X
Frederick HicksProcess Chemistry Development, Takeda Pharmaceuticals International, Cambridge, Massachusetts 02139, United States.
David K LeahyProcess Chemistry Development, Takeda Pharmaceuticals International, Cambridge, Massachusetts 02139, United States.ORCID https://orcid.org/0000-0003-4128-7792
Sachin HandaDepartment of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States.ORCID https://orcid.org/0000-0002-7635-5794
University of Louisville · USTakeda (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under the shielding effect of nanomicelles, a sustainable micellar technology for the design and convenient synthesis of ligand-free oxidizable ultrasmall Pd(0) nanoparticles (NPs) and their subsequent catalytic exploration for couplings of water-sensitive acid chlorides in water is reported. A proline-derived amphiphile, PS-750-M, plays a crucial role in stabilizing these NPs, preventing their aggregation and oxidation state changes. These NPs were characterized using

Identifiers

PMID34604859
PMCPMC8479868
OpenAlexW3184787681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.